Search

everythinglearnresearchcommunity

for

Search:↓

Skin issues in PCOS worsen quality of life and are linked to hormonal imbalances.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The article concludes that early diagnosis and lifestyle changes can prevent complications from high uric acid levels.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Early hair loss may indicate prostate issues.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.